296 related articles for article (PubMed ID: 16968899)
21. T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.
Roszik J; Sebestyén Z; Govers C; Guri Y; Szöor A; Pályi-Krekk Z; Vereb G; Nagy P; Szöllosi J; Debets R
Eur J Immunol; 2011 May; 41(5):1288-97. PubMed ID: 21469084
[TBL] [Abstract][Full Text] [Related]
22. Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer.
Calogero A; Hospers GA; Krüse KM; Schrier PI; Mulder NH; Hooijberg E; de Leij LF
Anticancer Res; 2000; 20(3A):1793-9. PubMed ID: 10928109
[TBL] [Abstract][Full Text] [Related]
23. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
[TBL] [Abstract][Full Text] [Related]
24. Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity.
Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Nishimura MI; Cole DJ
J Immunol; 2003 Feb; 170(3):1209-17. PubMed ID: 12538678
[TBL] [Abstract][Full Text] [Related]
25. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
[TBL] [Abstract][Full Text] [Related]
26. A retroviral vector that directs simultaneous expression of alpha and beta T cell receptor genes.
Pogulis RJ; Pease LR
Hum Gene Ther; 1998 Oct; 9(15):2299-304. PubMed ID: 9794213
[TBL] [Abstract][Full Text] [Related]
27. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Dietrich PY; Le Gal FA; Dutoit V; Pittet MJ; Trautman L; Zippelius A; Cognet I; Widmer V; Walker PR; Michielin O; Guillaume P; Connerotte T; Jotereau F; Coulie PG; Romero P; Cerottini JC; Bonneville M; Valmori D
J Immunol; 2003 May; 170(10):5103-9. PubMed ID: 12734356
[TBL] [Abstract][Full Text] [Related]
28. General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses.
den Haan JM; Mutis T; Blokland E; IJzerman AP; Goulmy E
Blood; 2002 Feb; 99(3):985-92. PubMed ID: 11807003
[TBL] [Abstract][Full Text] [Related]
29. Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor.
Brocker T; Riedinger M; Karjalainen K
Eur J Immunol; 1996 Aug; 26(8):1770-4. PubMed ID: 8765019
[TBL] [Abstract][Full Text] [Related]
30. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.
Inaguma Y; Akahori Y; Murayama Y; Shiraishi K; Tsuzuki-Iba S; Endoh A; Tsujikawa J; Demachi-Okamura A; Hiramatsu K; Saji H; Yamamoto Y; Yamamoto N; Nishimura Y; Takahashi T; Kuzushima K; Emi N; Akatsuka Y
Gene Ther; 2014 Jun; 21(6):575-84. PubMed ID: 24694533
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568
[TBL] [Abstract][Full Text] [Related]
32. Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells.
van Loenen MM; Hagedoorn RS; Kester MG; Hoogeboom M; Willemze R; Falkenburg JH; Heemskerk MH
Cancer Res; 2009 Mar; 69(5):2034-41. PubMed ID: 19223543
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
34. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety.
Ochi T; Fujiwara H; Okamoto S; An J; Nagai K; Shirakata T; Mineno J; Kuzushima K; Shiku H; Yasukawa M
Blood; 2011 Aug; 118(6):1495-503. PubMed ID: 21673345
[TBL] [Abstract][Full Text] [Related]
35. A fast and robust method to clone and functionally validate T-cell receptors.
Birkholz K; Hofmann C; Hoyer S; Schulz B; Harrer T; Kämpgen E; Schuler G; Dörrie J; Schaft N
J Immunol Methods; 2009 Jul; 346(1-2):45-54. PubMed ID: 19427315
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
Yang X; Chen G; Weng NP; Mariuzza RA
J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
Front Immunol; 2019; 10():2076. PubMed ID: 31552033
[TBL] [Abstract][Full Text] [Related]
38. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
39. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
Man S; Ridge JP; Engelhard VH
J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
[TBL] [Abstract][Full Text] [Related]
40. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
